Patents by Inventor Grant Bonavia

Grant Bonavia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Matrices for drug delivery and methods for making and using the same
    Publication number: 20070098807
    Abstract: In one aspect, biocompatible matrices such as sol-gels encapsulating a reaction center may be administered to a subject for conversion of prodrugs into biologically active agents. In certain embodiments, the biocompatible matrices of the present invention are sol-gels. In one embodiment, the enzyme L-amino acid decarboxylase is encapsulated and implanted in the brain to convert L-dopa to dopamine for treatment of Parkinson's disease.
    Type: Application
    Filed: May 15, 2006
    Publication date: May 3, 2007
    Inventors: John Babich, Jon Zubieta, Grant Bonavia
  • Matrices for drug delivery and methods for making and using the same
    Patent number: 7052913
    Abstract: In one aspect, biocompatible matrices such as sol-gels encapsulating a reaction center may be administered to a subject for conversion of prodrugs into biologically active agents. In certain embodiments, the biocompatible matrices of the present invention are sol-gels. In one embodiment, the enzyme L-amino acid decarboxylase is encapsulated and implanted in the brain to convert L-dopa to dopamine for treatment of Parkinson's disease.
    Type: Grant
    Filed: May 4, 2004
    Date of Patent: May 30, 2006
    Assignee: Molecular Insight Pharmaceuticals, Inc.
    Inventors: John W. Babich, Jon Zubieta, Grant Bonavia
  • Matrices for drug delivery and methods for making and using the same
    Publication number: 20040241205
    Abstract: In one aspect, biocompatible matrices such as sol-gels encapsulating a reaction center may be administered to a subject for conversion of prodrugs into biologically active agents. In certain embodiments, the biocompatible matrices of the present invention are sol-gels. In one embodiment, the enzyme L-amino acid decarboxylase is encapsulated and implanted in the brain to convert L-dopa to dopamine for treatment of Parkinson's disease.
    Type: Application
    Filed: May 4, 2004
    Publication date: December 2, 2004
    Inventors: John W. Babich, Jon Zubieta, Grant Bonavia
  • Matrices for drug delivery and methods for making and using the same
    Publication number: 20030082238
    Abstract: In one aspect, biocompatible matrices such as sol-gels encapsulating a reaction center may be administered to a subject for conversion of prodrugs into biologically active agents. In certain embodiments, the biocompatible matrices of the present invention are sol-gels. In one embodiment, the enzyme L-amino acid decarboxylase is encapsulated and implanted in the brain to convert L-dopa to dopamine for treatment of Parkinson's disease.
    Type: Application
    Filed: February 15, 2002
    Publication date: May 1, 2003
    Inventors: John W. Babich, Jon Zubieta, Grant Bonavia
  • Matrices for drug delivery and methods for making and using the same
    Patent number: 6395299
    Abstract: In one aspect, biocompatible matrices such as sol-gels encapsulating a reaction center may be administered to a subject for conversion of prodrugs into biologically active agents. In certain embodiments, the biocompatible matrices of the present invention are sol-gels. In one embodiment, the enzyme L-amino acid decarboxylase is encapsulated and implanted in the brain to convert L-dopa to dopamine for treatment of Parkinson's disease.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: May 28, 2002
    Assignee: Biostream, Inc.
    Inventors: John W. Babich, Jon Zubieta, Grant Bonavia